Position in SIBN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,447,836
+$1,761,071 QoQ
Shares Held
395,088
+6.5% QoQ
Ownership
0.882%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#28
of 168 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIBN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $200,471,862 across 21 Medical Devices names. SIBN ranks #13 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESTA |
Establishment Labs Holdings Inc.
|
472,316 | $40,529,435 | |
| 2 | BVS |
Bioventus Inc.
|
1,833,212 | $17,305,521 | |
| 3 | APYX |
Apyx Medical Corp
|
3,274,064 | $14,700,547 | |
| 4 | AORT |
Artivion, Inc.
|
639,282 | $14,364,666 | |
| 5 | ENOV |
Enovis CORP
|
662,183 | $13,707,188 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
|
900,590 | $13,589,903 | |
| 7 | UFPT |
Ufp Technologies Inc
|
44,465 | $11,789,005 | |
| 8 | CBLL |
Ceribell, Inc.
|
605,010 | $11,767,444 |
All Filings in SIBN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,447,836 | 395,088 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,686,765 | 371,082 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,838,441 | 296,067 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,385,390 | 162,051 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,070,802 | 110,032 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,543,748 | 110,032 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,542,200 | 110,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,537,800 | 110,000 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,874,850 | 145,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,373,650 | 145,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,043,550 | 145,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,803,680 | 132,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,561,360 | 132,000 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,596,440 | 132,000 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $1,305,600 | 96,000 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $1,169,820 | 67,000 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,082,400 | 82,000 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,853,200 | 82,000 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,821,220 | 82,000 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,263,508 | 152,358 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $7,469,656 | 237,358 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $8,073,378 | 253,800 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $20,681,830 | 691,700 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $7,818,112 | 329,600 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,024,942 | 64,300 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||